Skip to main content
Clinical Trials/CTRI/2024/04/065549
CTRI/2024/04/065549
Not yet recruiting
未知

Disorganization of retinal inner layers as a biomarker in patients with center involving diabetic macular oedema treated with intravitreal bevacizumab - NI

K P Salve Institute of Medical Sciences and Research Centre , Nagpur0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H357- Separation of retinal layers
Sponsor
K P Salve Institute of Medical Sciences and Research Centre , Nagpur
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
K P Salve Institute of Medical Sciences and Research Centre , Nagpur

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients above 18 years of age, compliant for follow\-up and willing to participate
  • 2\.Patients of type I and type II Diabetes mellitus presenting with diabetic macular oedema resulting in visual loss
  • 3\.Study eye having best corrected visual acuity of less than 6/12\. Macular oedema defined clinically and by SD\- OCT as retinal thickness of more than 250µm in the central sub\-field and presence of intra or sub\-retinal fluid .
  • 4\.Treatment with intravitreal bevacizumab (atleast one injection) in past 6 months.

Exclusion Criteria

  • 1\.Other retinal diseases which can cause macular oedema like retinal vascular disorders, choroidal neovascular membrane secondary to age related macular degeneration or any other cause, uveitis
  • 2\.Recent history of any intraocular surgery leading to macular oedema
  • 3\.Any other cause of loss of visual acuity except cataract

Outcomes

Primary Outcomes

Not specified

Similar Trials